com.insightguru.giraffe.server.utils.PresentationUtil$PresentationTitle@4fa0e4c9
This site requires JavaScript to function properly.
For help enabling JavaScript click here.
Here are some sample widgets you could interact with from this dashboard:
(1) Revenues expected to be slightly below consensus estimates
Trefis estimates MRK's Q3 2021 revenues to be $12.2 Bil, slightly below the consensus estimate of $12.3 Bil
Estimated Revenues - 2021Q3(E)
![]()
Trefis Estimates for Merck Revenues:
Expected Change (YoY): -2.6%
The chart to the right highlights trends in Merck's Revenues over the last four quarters along with our forecast for Q3 2021.
Quarterly Revenue Trend
![]()
(2) EPS likely to marginally miss consensus estimates
MRK's Q3 2021 earnings per share (EPS) expected to be $1.48 per Trefis analysis, marginally missing the consensus estimate of $1.54 by 3.9%
Estimated EPS- 2021Q3(E)
![]()
Trefis Estimates for Merck EPS:
Expected Change (YoY): 27.6%
The chart to the right highlights trends in MRK's EPS over the last four quarters along with our forecast for Q3 2021.
Quarterly EPS Trend
![]()
(3) Stock price estimate 12% higher than current market price
Trefis maintains a fair value of $91 for MRK's stock as opposed to the current market price of roughly $81.
MRK Stock Price
![]()
The Trefis Price Estimate for Merck stock represents the fair value for the company's stock over a one-year horizon.
Details about the chances of a rise in MRK stock in the near term can be found in a separate interactive dashboard.
The chart to the right highlights trends in MRK's stock price at the end of each of the last four quarters as well as the current stock price.
Stock Price (Quarter End)
![]()
#1. Estimating Merck's Total Revenues:
Merck's Revenues have seen a increase of 13.5% from around $42 Bil in FY2018 to $48 Bil in FY2020 and we expect it to increase to $48 Bil in FY2021
Total Revenue
![]()
A Separate Interactive Dashboard Analysis On Merck's Revenues Details How The Company Makes Money.
#2. Deriving Merck's Adjusted Net Income:
Merck's Adjusted Net Income has increased from around $12 Bil in FY2018 to $15 Bil in FY2020 and we expect it to fall to $14 Bil in FY2021
This change is likely to be led by higher revenues and weaker margins.
A Separate Interactive Dashboard Analysis On Merck's Margins Highlights The Company's Various Expenses Components In Detail.
Adjusted Net Income [AxB]
![]()
Adjusted Net Income Margin [A]
![]()
Total Revenue [B]
![]()
#3. Determining Merck's Adjusted EPS:
Merck's Adjusted EPS has increased from $4.34 in FY2018 to $5.94 in FY2020 and we expect it to fall to $5.65 in FY2021
The change in EPS can be attributed to a reduction in adjusted net income and a lower expected share count due to stock repurchases.
Adjusted EPS [A÷B]
![]()
Adjusted Net Income [A]
![]()
Shares Outstanding [B]
![]()
#4. Estimating Merck's Share Price:
Our Price Estimate of $91 For Merck's Stock is based on our Detailed Valuation Model, and implies a 16.2x P/E Multiple on expected FY2021 Adjusted EPS of $5.65
Trefis Price Estimate [AxB]
![]()
Adjusted EPS [A]
![]()
P/E Multiple [B]
![]()
